{"id":"https://openalex.org/W93601657","doi":null,"title":"An antibody against Amyloid-\u03b2 protofibrils mediates their clearance and prevents amyloid formation in a mouse model of Alzheimer\u2019s disease","display_name":"An antibody against Amyloid-\u03b2 protofibrils mediates their clearance and prevents amyloid formation in a mouse model of Alzheimer\u2019s disease","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W93601657","mag":"93601657"},"language":"en","primary_location":{"id":"mag:93601657","doi":null,"is_oa":false,"landing_page_url":"http://www.diva-portal.org/smash/record.jsf?pid=diva2:175087","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077335871","display_name":"Anna Lord","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Lord","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006377510","display_name":"Astrid Gumucio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Astrid Gumucio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038514040","display_name":"Hillevi Englund","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hillevi Englund","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055348919","display_name":"Dag Sehlin","orcid":"https://orcid.org/0000-0002-9430-3859","observed_orcids":["https://orcid.org/0000-0002-9430-3859"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dag Sehlin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9430-3859","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060318395","display_name":"Valentina Screpanti Sundquist","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valentina Screpanti Sundquist","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111444392","display_name":"Linda S\u00f6derberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda S\u00f6derberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029246780","display_name":"Christer M\u00f6ller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christer M\u00f6ller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110406834","display_name":"P\u00e4r Gellerfors","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P\u00e4r Gellerfors","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018345023","display_name":"Lars Lannfelt","orcid":"https://orcid.org/0000-0001-9839-659X","observed_orcids":["https://orcid.org/0000-0001-9839-659X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lars Lannfelt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029284586","display_name":"Frida Ekholm Pettersson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frida Ekholm Pettersson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5014948868","display_name":"Lars N. G. Nilsson","orcid":"https://orcid.org/0000-0002-8362-1042","observed_orcids":["https://orcid.org/0000-0002-8362-1042"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lars Nilsson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8362-1042","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00734231,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amyloid-beta-protofibrils","display_name":"amyloid-beta protofibrils","score":0.9100000262260437},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9369999766349792},{"id":"https://openalex.org/keywords/arctic-mutation","display_name":"Arctic mutation","score":0.968999981880188},{"id":"https://openalex.org/keywords/swedish-mutation","display_name":"Swedish mutation","score":0.9049999713897705},{"id":"https://openalex.org/keywords/intraneuronal-amyloid-beta","display_name":"intraneuronal amyloid-beta","score":0.9670000076293945},{"id":"https://openalex.org/keywords/amyloid-plaques","display_name":"amyloid plaques","score":0.9150000214576721},{"id":"https://openalex.org/keywords/passive-immunization","display_name":"passive immunization","score":0.781000018119812},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.6589999794960022},{"id":"https://openalex.org/keywords/transgenic-mouse-model","display_name":"transgenic mouse model","score":0.8109999895095825},{"id":"https://openalex.org/keywords/amyloid-beta-immunotherapy","display_name":"amyloid-beta immunotherapy","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C68026918","wikidata":"https://www.wikidata.org/wiki/Q1970256","display_name":"Senile plaques","level":4,"score":0.792945146560669},{"id":"https://openalex.org/C141035611","wikidata":"https://www.wikidata.org/wiki/Q5532934","display_name":"Genetically modified mouse","level":4,"score":0.7161852121353149},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.6382008790969849},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.5838685035705566},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.5714410543441772},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5122853517532349},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.4541061818599701},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.4519665837287903},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.450653076171875},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.44290968775749207},{"id":"https://openalex.org/C31705614","wikidata":"https://www.wikidata.org/wiki/Q423510","display_name":"Amyloid precursor protein","level":4,"score":0.4255770444869995},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3429509401321411},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.30745428800582886},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.275346040725708},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25940370559692383},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23456242680549622},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23117122054100037},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1748512089252472},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13739609718322754}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:93601657","doi":null,"is_oa":false,"landing_page_url":"http://www.diva-portal.org/smash/record.jsf?pid=diva2:175087","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W108068136","https://openalex.org/W78572111","https://openalex.org/W2748926393","https://openalex.org/W48705720","https://openalex.org/W1979590358","https://openalex.org/W1983118299","https://openalex.org/W2152222652","https://openalex.org/W24177197","https://openalex.org/W2064080536","https://openalex.org/W1540282518"],"abstract_inverted_index":{"The":[0,19,82,99,132,172,283],"Arctic":[1,31,68,83,173],"mutation":[2,32,77,84,174],"causes":[3],"early-onset":[4],"Alzheimer\u2019s":[5],"disease":[6],"(AD),":[7],"and":[8,35,69,73,96,106,119,156,184,207,266,285,301],"makes":[9,293],"amyloid-\u03b2":[10,89],"(A\u03b2)":[11],"peptides":[12],"more":[13],"prone":[14],"to":[15,25,36,40,59,111,158],"form":[16],"A\u03b2":[17,48,116,128,134,155,206,254,291],"protofibrils.":[18],"aims":[20],"of":[21,29,44,47,88,108,114,126,140,204,253,280,288],"this":[22],"thesis":[23],"were":[24,80,151,214],"investigate":[26],"the":[27,30,42,53,75,103,123,185,201,208],"mechanisms":[28],"in":[33,52,93,102,117,129,135,162,180,220,256,304],"vivo,":[34],"use":[37],"transgenic":[38,94],"models":[39,66],"determine":[41],"role":[43],"early":[45,124,202,264,284],"intermediates":[46],"aggregation,":[49],"like":[50],"protofibrils,":[51],"pathogenesis.":[54],"In":[55],"addition,":[56],"we":[57],"aimed":[58],"evaluate":[60],"protofibrils":[61,141,167,213,233,249,269,289],"as":[62,216],"a":[63,197,217,227,295],"therapeutic":[64,218,302],"target.Transgenic":[65],"with":[67,74,137,153,223,261],"Swedish":[70,76],"mutations":[71],"(tg-ArcSwe),":[72],"alone":[78],"(tg-Swe)":[79],"created.":[81],"favored":[85],"amyloidogenic":[86],"processing":[87,107],"precursor":[90],"protein":[91],"(APP)":[92],"mice":[95,222],"cultured":[97],"cells.":[98],"observed":[100],"shift":[101],"subcellular":[104],"location":[105],"APP":[109],"led":[110],"increased":[112],"production":[113],"intracellular":[115],"vitro,":[118],"also":[120,175],"partly":[121],"explained":[122],"accumulation":[125,203],"intraneuronal":[127,133,154,193,205],"tg-ArcSwe":[130,182,221],"mice.":[131],"combination":[136],"enhanced":[138,176],"levels":[139,150],"appeared":[142],"long":[143],"before":[144],"extracellular":[145],"plaques":[146,260],"emerged.":[147],"Elevated":[148],"protofibril":[149],"associated":[152],"linked":[157],"spatial":[159],"learning":[160],"deficits":[161],"young":[163],"mice,":[164,183],"suggesting":[165],"that":[166,248],"cause":[168],"AD-related":[169],"cognitive":[170],"deficits.":[171],"senile":[177,210,236,259],"plaque":[178,187,211,239],"pathology":[179],"aged":[181],"accelerated":[186],"deposition":[188,279],"was":[189,241],"accompanied":[190],"by":[191],"decreased":[192],"A\u03b2.":[194,282],"This":[195,230],"suggests":[196],"dynamic":[198],"equilibrium":[199],"between":[200],"later":[209],"pathology.A\u03b2":[212],"evaluated":[215],"target":[219,297],"passive":[224],"immunization":[225],"using":[226],"protofibril-selective":[228],"antibody.":[229],"treatment":[231,244],"cleared":[232,273],"without":[234],"removing":[235],"plaques.":[237],"However,":[238],"formation":[240],"prevented":[242],"if":[243],"began":[245],"early,":[246],"indicating":[247],"are":[250],"intermediate":[251],"species":[252],"fibrillization":[255],"vivo.":[257],"Targeting":[258],"immunotherapy":[262],"requires":[263],"diagnosis":[265],"intervention,":[267],"whereas":[268],"can":[270],"be":[271],"specifically":[272],"from":[274],"brain":[275],"despite":[276],"substantial":[277],"AD-like":[278],"insoluble":[281],"persistent":[286],"presence":[287],"throughout":[290],"amyloidosis":[292],"them":[294],"promising":[296],"for":[298],"future":[299],"diagnostic":[300],"strategies":[303],"AD.":[305]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}